Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, announced today that an overview of the company's business strategy and development-stage programs will be given at the Guggenheim Healthcare Talks Idea Forum Oncology Day being held in New York. The company presentation is on Thursday, February 13, 2020, at 4:00 PM EST.
hab meine Posi die letzten Tage erstmal aufgelöst. War ne gute Entscheidung...aktuell geht`s weiter runter. Morgen Q-Zahlen?! Mal sehen, was die bringen
Data from poziotinib Cohort 1 of ZENITH20 accepted for podium presentation on March 18 at 11th Annual Congress on Pulmonary and Respiratory Medicine in Amsterdam
"Based on current operating plans, Spectrum expects that SG&A expense will increase in the second half of this year as we scale up our commercial operations in preparation to launch ROLONTIS."